Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice
- 1 April 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (7) , 624-632
- https://doi.org/10.1038/sj.gt.3301131
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 28 references indexed in Scilit:
- GENERATION OF HUMAN LYMPHOKINE-ACTIVATED KILLER CELLS FOLLOWING AN IL-2 PULSE IN ELDERLY CANCER PATIENTSCytokine, 1998
- ImmunosenescenceImmunology Today, 1997
- Cytokines, tumour-cell death and immunogenicity: a question of choiceImmunology Today, 1997
- The Aging Immune System: Primer and ProspectusScience, 1996
- Thymic involution with ageing: obsolescence or good housekeeping?Immunology Today, 1996
- Adjuvant effect of low-dose interleukin-2 on antibody response to influenza virus vaccination in healthy elderly subjectsMechanisms of Ageing and Development, 1994
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Age-related impairment of early and late events of signal transduction in mouse immune cellsLife Sciences, 1993
- Effect of thymus grafts of various ages on the immune system formation in CBA miceMechanisms of Ageing and Development, 1985
- The effect of sequential multiple grafting of syngeneic newborn thymus on the immune functions and life expectancy of aging miceMechanisms of Ageing and Development, 1984